XML 69 R53.htm IDEA: XBRL DOCUMENT v3.25.0.1

SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues by product category and segment profits for the years 2024, 2023 and 2022 were as follows:

			For the year ended December 31, 2024
(in millions)			Salix						International						Solta Medical						Diversified						Bausch + Lomb						Total
Revenues:
Pharmaceuticals			$	2,330					$	248					$	—					$	849					$	969					$	4,396
Devices			—						—						440						—						1,800						2,240
OTC			—						173						—						6						1,724						1,903
Branded and Other generics			—						624						—						74						281						979
Other revenues			3						66						—						21						17						107
Total revenues			2,333						1,111						440						950						4,791						$	9,625
Less:
Cost of goods sold (excluding amortization and impairments of intangible assets)			174						449						98						140						1,868
Costs of other revenues			—						48						1						—						4
Selling, general and administrative			458						214						110						169						1,690
Research and development			99						24						18						15						121
Segment profit			$	1,602					$	376					$	213					$	626					$	1,108

			For the year ended December 31, 2023
(in millions)			Salix						International						Solta Medical						Diversified						Bausch + Lomb						Total
Revenues:
Pharmaceuticals			$	2,251					$	250					$	—					$	790					$	618					$	3,909
Devices			—						—						347						—						1,650						1,997
OTC			—						179						—						7						1,611						1,797
Branded and Other generics			—						588						—						120						252						960
Other revenues			(1)						54						—						26						15						94
Total revenues			2,250						1,071						347						943						4,146						$	8,757
Less:
Cost of goods sold (excluding amortization and impairments of intangible assets)			182						470						78						149						1,640
Costs of other revenues			—						38						—						—						2
Selling, general and administrative			416						205						88						190						1,402
Research and development			104						23						20						18						122
Segment profit			$	1,548					$	335					$	161					$	586					$	980

			For the year ended December 31, 2022
(in millions)			Salix						International						Solta Medical						Diversified						Bausch + Lomb						Total
Revenues:
Pharmaceuticals			$	2,090					$	258					$	—					$	826					$	468					$	3,642
Devices			—						—						300						—						1,572						1,872
OTC			—						151						—						7						1,461						1,619
Branded and Other generics			—						527						—						120						245						892
Other revenues			—						52						—						25						22						99
Total revenues			2,090						988						300						978						3,768						$	8,124
Less:
Cost of goods sold (excluding amortization and impairments of intangible assets)			189						421						66						130						1,510
Costs of other revenues			—						40						—						—						8
Selling, general and administrative			362						181						80						211						1,253
Research and development			50						22						19						25						123
Segment profit			$	1,489					$	324					$	135					$	612					$	874

The following table presents a reconciliation of total segment profit to total consolidated Income (loss) before income taxes for the years 2024, 2023 and 2022:

(in millions)			2024						2023						2022
Segment Profit
Salix			$	1,602					$	1,548					$	1,489
International			376						335						324
Solta Medical			213						161						135
Diversified			626						586						612
Bausch + Lomb			1,108						980						874
			3,925						3,610						3,434
Corporate			(994)						(933)						(828)
Amortization of intangible assets			(1,077)						(1,077)						(1,215)
Goodwill impairments			—						(493)						(824)
Asset impairments			(29)						(54)						(15)
Restructuring, integration, separation and IPO costs			(32)						(62)						(63)
Other expense, net			(247)						(28)						(35)
Operating income			1,546						963						454
Interest income			33						26						14
Interest expense			(1,388)						(1,328)						(1,464)
Gain on extinguishment of debt			23						1						875
Foreign exchange and other			(47)						(52)						(8)
Income (loss) before income taxes			$	167					$	(390)					$	(129)

Schedule of revenues by geographic region

Revenues are attributed to a geographic region based on the location of the customer and for the years 2024, 2023 and 2022, were as follows:

(in millions)			2024						2023						2022
U.S. and Puerto Rico			$	5,767					$	5,194					$	4,836
China			496						441						413
Canada			402						366						351
Poland			350						319						278
Mexico			315						322						276
France			230						214						203
Japan			188						194						200
Russia			161						148						181
Germany			159						152						147
South Korea			146						93						77
United Kingdom			135						125						115
Spain			99						92						84
Italy			94						86						76
Other			1,083						1,011						887
			$	9,625					$	8,757					$	8,124

Schedule of long-lived assets by geographic region

Long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, are attributed to geographic regions based on their physical location and as of December 31, 2024 and 2023 were as follows:

(in millions)			2024						2023
U.S. and Puerto Rico			$	876					$	750
Ireland			425						400
Germany			104						98
Other			375						459
			$	1,780					$	1,707

Schedule of major customers

Customers that accounted for 10% or more of total revenues were as follows:

			2024						2023						2022
Cencora Inc.			19%						19%						18%
McKesson Corporation			15%						15%						15%
Cardinal Health, Inc.			14%						13%						13%

X

- Definition

Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration